BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Analogic Appoints Joseph Whitters to Board of Directors

  Mr. Whitters joins the Analogic Board with significant experience in healthcare, finance and strategic transactions.

  October 16, 2017

   · 

  4 min read
• Business

  Lilly Declares Fourth-Quarter 2017 Dividend

  The board of directors of Eli Lilly has declared a dividend for the fourth quarter of 2017 of $0.52 per share on outstanding common stock.

  October 16, 2017

   · 

  1 min read
• Drug Development

  Cara Therapeutics Announces Successful End-of-Phase II Meeting with FDA for I.V. CR845 in Chronic Kidney Disease-Associated Pruritus

  Cara, in consultation with the FDA, has established the key elements of the Phase 3 program to support a New Drug Application (NDA) for I.V. CR845.

  October 16, 2017

   · 

  5 min read
• Orthocell Granted Celgro Patent Protection In Canada

  Regenerative medicine company Orthocell Limited is pleased to announce it has been granted a Canadian patent for its CelGro collagen medical device platform for soft tissue regeneration and repair applications.

  October 16, 2017

   · 

  3 min read
• Business

  Henry Schein Medical Announces Exclusive Distribution Agreement With Terason® For Ultrasound Device

  Henry Schein Medical today announced that its EMS business has entered an exclusive agreement with Terason to distribute uSmart 3200T NexGen.

  October 16, 2017

   · 

  4 min read
• Biotech Beach

  CytRx Corp. Announces Outcome of Nasdaq Hearing

  CytRx Corp. today announced that Nasdaq has granted the Company’s request for a continued listing pending the results of a stockholder vote on or before October 30, 2017.

  October 16, 2017

   · 

  7 min read
• Valeant And One Of Its Subsidiaries Announce Early Tender Results And Early Settlement Date For Cash Tender Offers For Senior Notes

  Valeant announced today the results to date of the pending cash tender offers by Valeant and Valeant Pharmaceuticals International to purchase up to $1,000,000,000 aggregate principal amount of their respective outstanding notes.

  October 16, 2017

   · 

  10 min read
• Drug Development

  ZIOPHARM Oncology Announces First Patient Dosed in New Phase I Study of Ad-RTS-hIL-12 plus Veledimex for the Treatment of Pediatric Brain Tumors

  ZIOPHARM announced that the first patient has been dosed in a new Phase 1 study of Ad-RTS-hIL-12 with veledimex for the treatment of pediatric brain tumors.

  October 16, 2017

   · 

  7 min read
• Policy

  Novo Nordisk: FDA Posts Briefing Materials Prior To Advisory Committee Meeting for Semaglutide

  Novo Nordisk announced that the FDA has published the briefing documents ahead of the Advisory Committee meeting to discuss the NDA for approval of semaglutide.

  October 16, 2017

   · 

  1 min read
• Deals

  Week In Review: Shanghai Pharma Bids In Cardinal China’s $1.5 Billion Auction

  Shanghai Pharma and FountainVest Partners, a China PE fund, submitted second-round bids for Cardinal China’s $1.5 billion drug distribution operations.

  October 16, 2017

   · 

  1 min read